Further, in a streptozotocin-induced diabetic mouse model, FGF21 upregulated the ERK1/2 mitogen–activated protein kinase (p38 MAPK)/AMP-activated protein kinase (AMPK) pathway to protect against lipotoxicity-mediated cardiac apoptosis in diabetes [82]. The gene discussed is FGF21; the disease is diabetes mellitus.